Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Product type
3.2. Market Snippet by Test Type
3.3. Market Snippet by End-User
3.4. Market Snippet by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.2. Drivers
4.2.1. Rising Prevalence of Preeclampsia
4.2.2. Technological Advancements in Preeclampsia Diagnostic
4.3. Restraints:
4.3.1. Lack of awareness about Preeclampsia in developing countries
4.4. Opportunity
4.5. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Epidemiology
5.3. Supply Chain Analysis
5.4. Pricing Analysis
5.5. Regulatory Analysis
5.6. Technological Advancements
5.7. Unmet Needs
6. By Product Type
6.1. Introduction
6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment.
6.3. Market Attractiveness Index, By Product Type Segment
6.3.1. Instruments*
6.3.1.1. Introduction
6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
6.3.2. Consumables
7. By Test Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type Segment.
7.1.2. Market Attractiveness Index, By Test Type Segment
7.2. Blood Tests*
7.2.1. Introduction
7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3. Urine Analysis
8. By End-User
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment.
8.1.2. Market Attractiveness Index, By End-User Segment
8.2. Hospitals*
8.2.1. Introduction
8.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3. Diagnostic Centers
8.4. Specialty Clinics
8.5. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. The U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. The U.K.
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. Australia
9.5.6.5. Rest of Asia Pacific
9.6. The Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Diabetomics, Inc.*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. Thermo Fisher Scientific Inc.
11.3. F. Hoffmann-La Roche Ltd
11.4. PerkinElmer Inc.
11.5. Siemens Healthineers AG
11.6. DRG INSTRUMENTS GMBH
11.7. Metabolomic Diagnostics Ltd.
11.8. Bayer AG
11.9. Sera Prognostics (*List is not exhaustive)
12. DataM Intelligence
12.1. Appendix
12.2. About Us and Services
12.3. Contact Us